Niclosamide delayed-release composition and antiviral use thereof
AssigneesDaewoong Therapeutics Inc., Daewoong Pharmaceutical Co., Ltd.
InventorsMinsuk Lee, Bokki Kang, Sanghan Park, Donghwan Kim
Life of this patent
Estimating the term…
Abstract
The present invention relates to a pharmaceutical composition for prevention or treatment of coronavirus infections, comprising a delayed-release composition of niclosamide or a pharmaceutically acceptable salt thereof, and a method for preventing or treating coronavirus infections by using the same.
Claims1
A method of treating coronavirus infections, comprising administering to a subject in need thereof, via an intramuscular route, a pharmaceutical composition comprising (i) niclosamide or a pharmaceutically acceptable salt thereof, (ii) sodium carboxymethylcellulose, (iii) mannitol and (iv) sodium phosphate monobasic monohydrate,
- wherein the method requires maintaining a blood drug concentration of niclosamide in the subject for 20 days or longer following a single administration.
Dependencies are inferred from the claim text.